Merck & Co – known as MSD outside the US and Canada – has shared positive overall survival (OS) results from a late-stage ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Immunotherapy helpful in skin, breast, bladder cancers Immunotherapy ... Overall survival at five years was 86.6% with Keytruda plus chemotherapy before surgery and continued immunotherapy after ...

Today, the industry leader in wellness technology, Therabody, added five new innovations and four limited editions of bestselling products to their ecosystem of science-backed solutions. The latest ...

"Neoadjuvant therapy” refers to supplemental cancer treatment you receive before your primary treatment. Adjuvant therapies, ...

In July, MSD and Moderna decided to take the combination of the vaccine and Keytruda into a phase 3 trial called INTerpath-001 (formerly V940-001) for skin cancer melanoma, once again as an ...

Investorideas ( ), a go-to investing platform, releases the second of a two-part series looking at news and developments for the <a target=_blank ...